To include your compound in the COVID-19 Resource Center, submit it here.

Bydureon exenatide once weekly regulatory update

The European Commission approved an MAA from Eli Lilly for Bydureon exenatide once weekly to treat Type II

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE